Screening compound: C31H25FN2O5S (C529-0792)

Screening compound: C<sub>31</sub>H<sub>25</sub>FN<sub>2</sub>O<sub>5</sub>S (C529-0792)
Screening compound: C<sub>31</sub>H<sub>25</sub>FN<sub>2</sub>O<sub>5</sub>S (C529-0792) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C31H25FN2O5S (C529-0792)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C529-0792

Molecular Formula

C31H25FN2O5S (C31 H25 FN2 O5 S)

Compound Name

N~8~-[1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl]-10-(2-fluorobenzyl)-5,11-dioxo-10,11-dihydro-5H-5lambda~4~-dibenzo[b,f][1,4]thiazepine-8-carboxamide

IUPAC name

N-[1-(23-dihydro-14-benzodioxin-6-yl)ethyl]-9-[(2-fluorophenyl)methyl]-210-dioxo-2lambda4-thia-9-azatricyclo[9.4.0.0^{38}]pentadeca-1(11)3(8)461214-hexaene-6-carboxamide

SMILES

CC(c(cc1)cc2c1OCCO2)NC(c(cc1)cc(N(Cc(cccc2)c2F)C(c2c3cccc2)=O)c1S3=O)=O

InChI

InChI=1S/C31H27FN2O5S/c1-19(20-10-12-26-27(17-20)39-15-14-38-26)33-30(35)21-11-13-29-25(16-21)34(18-22-6-2-4-8-24(22)32)31(36)23-7-3-5-9-28(23)40(29)37/h2-13,16-17,19H,14-15,18,40H2,1H3,(H,33,35)

InChI Key

RVQFSDVZMGVYQB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14767387

C31H25FN2O5S (C529-0792) in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Protein-Protein Interaction Library (218420 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
Targets:
  • GPCR
  • Phosphatases
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with C31H25FN2O5S (C529-0792) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C31H25FN2O5S (C529-0792)?
Check Price and Availability of C31H25FN2O5S (C529-0792), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C31H25FN2O5S (C529-0792) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C31H25FN2O5S (C529-0792)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C31H25FN2O5S (C529-0792)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C31H25FN2O5S (C529-0792) available by request